We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

26 hedge funds and large institutions have $4.45M invested in Enveric Biosciences in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

718% more call options, than puts

Call options by funds: $368K | Put options by funds: $45K

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

44% more funds holding

Funds holding: 18 → 26 (+8)

0% more ownership

Funds ownership: 0% → 0% (+0%)

4% less capital invested

Capital invested by funds: $4.64M → $4.45M (-$195K)

Holders
26
Holders Change
+8
Holders Change %
+44.44%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
2
Closed
1
Calls
$368K
Puts
$45K
Net Calls
+$323K
Net Calls Change
-$308K

Top Buyers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
+$1.15M
2
IC
Ikarian Capital
Texas
+$618K
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$618K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$422K
5
AI
AdvisorShares Investments
Maryland
+$408K

Top Sellers

Rank Fund Capital Flow
1
IWC
Integrated Wealth Concepts
Massachusetts
-$56.2K
2
SC
Scotia Capital
Ontario, Canada
-$42.2K
3
Squarepoint
Squarepoint
New York
-$27K
4
TRCT
Tower Research Capital (TRC)
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$707K +$422K +30 +55%
PVI
2
Pura Vida Investments
New York
$690K +$1.15M +82 New
Renaissance Technologies
3
Renaissance Technologies
New York
$515K +$98.4K +7 +13%
BlackRock
4
BlackRock
New York
$466K – – –
IC
5
Ikarian Capital
Texas
$372K +$618K +44 New
Mirae Asset Global Investments
6
Mirae Asset Global Investments
South Korea
$365K +$618K +44 New
AI
7
AdvisorShares Investments
Maryland
$279K +$408K +29 +725%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$154K +$84.3K +6 +46%
Citadel Advisors
9
Citadel Advisors
Florida
$144K +$98.4K +7 +70%
VF
10
Virtu Financial
New York
$131K +$141K +10 +167%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$129K +$126K +9 +150%
State Street
12
State Street
Massachusetts
$83K – – –
SC
13
Scotia Capital
Ontario, Canada
$62K -$42.2K -3 -30%
Goldman Sachs
14
Goldman Sachs
New York
$55K +$98.4K +7 New
Group One Trading
15
Group One Trading
Illinois
$49K +$84.3K +6 New
BFM
16
Boothbay Fund Management
New York
$41K +$70.3K +5 New
Two Sigma Investments
17
Two Sigma Investments
New York
$39K – – –
Northern Trust
18
Northern Trust
Illinois
$34K – – –
EGM
19
Engineers Gate Manager
New York
$31K +$14.1K +1 +33%
VIA
20
Vident Investment Advisory
Georgia
$24K – – –
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$19K +$28.1K +2 New
Creative Planning
22
Creative Planning
Kansas
$16K – – –
UBS Group
23
UBS Group
Switzerland
$13K +$28.1K +2 New
IWC
24
Integrated Wealth Concepts
Massachusetts
$10K -$56.2K -4 -80%
CG
25
Cutler Group
California
$5K – – –
1
2

ENVB Hedge Fund Activity: Q4 2021 in Review

26 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q4 2021, worth a combined $4.45M — down 4.2% from $4.64M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ENVB positions and 1 closed out — a net gain of 8 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Pura Vida Investments, opening a new position worth an estimated $1.15M. The largest seller was Integrated Wealth Concepts, cutting an estimated $56.2K.

  • 26 institutional investors held Enveric Biosciences (ENVB) as of Q4 2021, up from 18 in Q3 2021.
  • Funds reported $4.45M of Enveric Biosciences stock for Q4 2021, down 4.2% quarter-over-quarter.
  • 9 funds opened new Enveric Biosciences positions in Q4 2021 and 1 closed out, a net change of +8 holders.
  • The largest Enveric Biosciences buyer in Q4 2021 was Pura Vida Investments, an estimated $1.15M added.
  • The largest Enveric Biosciences seller in Q4 2021 was Integrated Wealth Concepts, an estimated $56.2K sold.

Based on aggregated 13F filings for Q4 2021.